These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 26229689)

  • 1. Neural Plasticity in Multiple Sclerosis: The Functional and Molecular Background.
    Ksiazek-Winiarek DJ; Szpakowski P; Glabinski A
    Neural Plast; 2015; 2015():307175. PubMed ID: 26229689
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasticity of the motor system in multiple sclerosis.
    Zeller D; Classen J
    Neuroscience; 2014 Dec; 283():222-30. PubMed ID: 24881573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synaptic plasticity and PDGF signaling defects underlie clinical progression in multiple sclerosis.
    Mori F; Rossi S; Piccinin S; Motta C; Mango D; Kusayanagi H; Bergami A; Studer V; Nicoletti CG; Buttari F; Barbieri F; Mercuri NB; Martino G; Furlan R; Nisticò R; Centonze D
    J Neurosci; 2013 Dec; 33(49):19112-9. PubMed ID: 24305808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional brain reorganization in multiple sclerosis: evidence from fMRI studies.
    Pantano P; Mainero C; Caramia F
    J Neuroimaging; 2006 Apr; 16(2):104-14. PubMed ID: 16629730
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exercise and brain health--implications for multiple sclerosis: Part 1--neuronal growth factors.
    White LJ; Castellano V
    Sports Med; 2008; 38(2):91-100. PubMed ID: 18201113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cerebral plasticity in multiple sclerosis: insights from fMRI.
    Cifelli A; Matthews PM
    Mult Scler; 2002 May; 8(3):193-9. PubMed ID: 12120689
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy-induced plasticity of cognitive functions in MS patients: insights from fMRI.
    Penner IK; Kappos L; Rausch M; Opwis K; Radü EW
    J Physiol Paris; 2006 Jun; 99(4-6):455-62. PubMed ID: 16713204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of individual cognitive profile on visuo-motor reorganization in relapsing-remitting multiple sclerosis.
    Gioia MC; Cerasa A; Liguori M; Passamonti L; Condino F; Vercillo L; Valentino P; Clodomiro A; Quattrone A; Fera F
    Brain Res; 2007 Sep; 1167():71-9. PubMed ID: 17689504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synaptic plasticity and experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
    Di Filippo M; de Iure A; Durante V; Gaetani L; Mancini A; Sarchielli P; Calabresi P
    Brain Res; 2015 Sep; 1621():205-13. PubMed ID: 25498984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Do some neurological conditions induce brain plasticity processes?
    Manning L
    Behav Brain Res; 2008 Sep; 192(1):143-8. PubMed ID: 18479763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune dysregulation and cognitive vulnerability in the aging brain: Interactions of microglia, IL-1β, BDNF and synaptic plasticity.
    Patterson SL
    Neuropharmacology; 2015 Sep; 96(Pt A):11-8. PubMed ID: 25549562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased endocannabinoid levels in the brain and beneficial effects of agents activating cannabinoid and/or vanilloid receptors in a rat model of multiple sclerosis.
    Cabranes A; Venderova K; de Lago E; Fezza F; Sánchez A; Mestre L; Valenti M; García-Merino A; Ramos JA; Di Marzo V; Fernández-Ruiz J
    Neurobiol Dis; 2005 Nov; 20(2):207-17. PubMed ID: 16242629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disturbed function and plasticity in multiple sclerosis as gleaned from functional magnetic resonance imaging.
    Filippi M; Rocca MA
    Curr Opin Neurol; 2003 Jun; 16(3):275-82. PubMed ID: 12858062
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain-derived neurotrophic factor and TrkB receptor in experimental autoimmune encephalomyelitis and multiple sclerosis.
    De Santi L; Annunziata P; Sessa E; Bramanti P
    J Neurol Sci; 2009 Dec; 287(1-2):17-26. PubMed ID: 19758606
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cerebrospinal fluid derived from progressive multiple sclerosis patients promotes neuronal and oligodendroglial differentiation of human neural precursor cells in vitro.
    Cristofanilli M; Cymring B; Lu A; Rosenthal H; Sadiq SA
    Neuroscience; 2013 Oct; 250():614-21. PubMed ID: 23876320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Role of fMRI in the Assessment of Neuroplasticity in MS: A Systematic Review.
    Laura G; Silvia T; Nikolaos P; Patrizia P
    Neural Plast; 2018; 2018():3419871. PubMed ID: 30693023
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fingolimod increases brain-derived neurotrophic factor levels and ameliorates amyloid β-induced memory impairment.
    Fukumoto K; Mizoguchi H; Takeuchi H; Horiuchi H; Kawanokuchi J; Jin S; Mizuno T; Suzumura A
    Behav Brain Res; 2014 Jul; 268():88-93. PubMed ID: 24713151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive deficits in multiple sclerosis: a review of functional MRI studies.
    Caramia F; Tinelli E; Francia A; Pozzilli C
    Neurol Sci; 2010 Nov; 31(Suppl 2):S239-43. PubMed ID: 20694492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional MRI in multiple sclerosis.
    Rocca MA; Filippi M
    J Neuroimaging; 2007 Apr; 17 Suppl 1():36S-41S. PubMed ID: 17425733
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.